Your browser doesn't support javascript.
loading
Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in A Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease.
Gouard, Sébastien; Maurel, Catherine; Marionneau-Lambot, Séverine; Dansette, Delphine; Bailly, Clément; Guérard, François; Chouin, Nicolas; Haddad, Ferid; Alliot, Cyril; Gaschet, Joëlle; Eychenne, Romain; Kraeber-Bodéré, Françoise; Chérel, Michel.
Afiliação
  • Gouard S; Université de Nantes, CNRS, Inserm, CRCINA, F-44000 Nantes, France.
  • Maurel C; Université de Nantes, CNRS, Inserm, CRCINA, F-44000 Nantes, France.
  • Marionneau-Lambot S; Department of nuclear medicine, Université de Nantes, CHU de Nantes, CNRS, Inserm, CRCINA, F-44000 Nantes, France.
  • Dansette D; Centre Hospitalier Départemental de Vendée, F-85925 La Roche-Sur-Yon, France.
  • Bailly C; Department of nuclear medicine, Université de Nantes, CHU de Nantes, CNRS, Inserm, CRCINA, F-44000 Nantes, France.
  • Guérard F; Université de Nantes, CNRS, Inserm, CRCINA, F-44000 Nantes, France.
  • Chouin N; Université de Nantes, CNRS, Inserm, CRCINA, F-44000 Nantes, France.
  • Haddad F; ONIRIS, F-44000 Nantes, France.
  • Alliot C; Université de Nantes, IMT Atlantique, CNRS, Subatech, F-44000 Nantes, France.
  • Gaschet J; Groupement d'Intérêt Public Arronax, F-44800 Saint-Herblain, France.
  • Eychenne R; Université de Nantes, CNRS, Inserm, CRCINA, F-44000 Nantes, France.
  • Kraeber-Bodéré F; Groupement d'Intérêt Public Arronax, F-44800 Saint-Herblain, France.
  • Chérel M; Université de Nantes, CNRS, Inserm, CRCINA, F-44000 Nantes, France.
Cancers (Basel) ; 12(9)2020 Sep 22.
Article em En | MEDLINE | ID: mdl-32971984

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article